Exact Mass: 638.3666

Exact Mass Matches: 638.3666

Found 38 metabolites which its exact mass value is equals to given mass value 638.3666, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

26-Glucosyl-1,3,11,22-tetrahydroxyergosta-5,24-dien-26-oate

3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl (2Z)-5-hydroxy-2,3-dimethyl-6-{3,5,17-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-14-yl}hept-2-enoic acid

C34H54O11 (638.3666)


26-Glucosyl-1,3,11,22-tetrahydroxyergosta-5,24-dien-26-oate is found in fruits. 26-Glucosyl-1,3,11,22-tetrahydroxyergosta-5,24-dien-26-oate is a constituent of Physalis peruviana (Cape gooseberry). Constituent of Physalis peruviana (Cape gooseberry). 26-Glucosyl-1,3,11,22-tetrahydroxyergosta-5,24-dien-26-oate is found in fruits.

   

19-Deacetylallofusicoccin

19-Deacetylallofusicoccin

C34H54O11 (638.3666)


   

19-Deacetylisofusicoccin

19-Deacetylisofusicoccin

C34H54O11 (638.3666)


   

12-O-Acetyldideacetylfusicoccin

12-O-Acetyldideacetylfusicoccin

C34H54O11 (638.3666)


   

Monodeacetylfusicoccin

Monodeacetylfusicoccin

C34H54O11 (638.3666)


   
   

25-chlorodeoxycimigenol-3-O-beta-D-xylopyranoside|25-chlorodeoxycimigenol-3-O-beta-D-xyloside

25-chlorodeoxycimigenol-3-O-beta-D-xylopyranoside|25-chlorodeoxycimigenol-3-O-beta-D-xyloside

C35H55ClO8 (638.3585)


   

26-[(beta-D-glucopyranosyl)oxy]-22alpha-methoxyfurosta-5,25(27)-diene-1beta,3beta,11alpha-triol|helleboroside A

26-[(beta-D-glucopyranosyl)oxy]-22alpha-methoxyfurosta-5,25(27)-diene-1beta,3beta,11alpha-triol|helleboroside A

C34H54O11 (638.3666)


   

solanolactoside A

solanolactoside A

C34H54O11 (638.3666)


   

26-Glucosyl-1,3,11,22-tetrahydroxyergosta-5,24-dien-26-oate

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2Z)-5-hydroxy-2,3-dimethyl-6-{3,5,17-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-14-yl}hept-2-enoate

C34H54O11 (638.3666)


   

xmd17-109

xmd17-109

C36H46N8O3 (638.3693)


XMD17-109 is a novel, specific ERK-5 inhibitor, with an IC50 of 162 nM.

   

6,13-Bis(triisopropylsilylethynyl)pentacene

6,13-Bis(triisopropylsilylethynyl)pentacene

C44H54Si2 (638.3764)


   

[(5R,6E,8E,10E,13S,14R,15R,16Z)-15,22,24-trihydroxy-5-methoxy-14,16-dimethyl-3-oxo-2-azabicyclo[18.3.1]tetracosa-1(23),6,8,10,16,20(24),21-heptaen-13-yl] (2R)-2-(cyclohexanecarbonylamino)propanoate

[(5R,6E,8E,10E,13S,14R,15R,16Z)-15,22,24-trihydroxy-5-methoxy-14,16-dimethyl-3-oxo-2-azabicyclo[18.3.1]tetracosa-1(23),6,8,10,16,20(24),21-heptaen-13-yl] (2R)-2-(cyclohexanecarbonylamino)propanoate

C36H50N2O8 (638.3567)


   

2-[[(2R)-3-acetyloxy-2-[7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]heptanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2R)-3-acetyloxy-2-[7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]heptanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H57NO11P+ (638.3669)


   

2-[[(2R)-2-acetyloxy-3-[7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]heptanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2R)-2-acetyloxy-3-[7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]heptanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H57NO11P+ (638.3669)


   

(2R)-4-amino-2-[[(2R)-4-amino-2-[3-[[(3R,5R,7S,8E,10E,12E)-3-amino-5-hydroxy-7-methoxyoctadeca-8,10,12-trienoyl]amino]propanoylamino]-4-oxobutanoyl]amino]-4-oxobutanoic acid

(2R)-4-amino-2-[[(2R)-4-amino-2-[3-[[(3R,5R,7S,8E,10E,12E)-3-amino-5-hydroxy-7-methoxyoctadeca-8,10,12-trienoyl]amino]propanoylamino]-4-oxobutanoyl]amino]-4-oxobutanoic acid

C30H50N6O9 (638.3639)


   
   
   
   

PA P-18:1/13:5;O2

PA P-18:1/13:5;O2

C34H55O9P (638.3584)


   

PA 18:3/13:3;O

PA 18:3/13:3;O

C34H55O9P (638.3584)


   

PA 20:4/11:2;O

PA 20:4/11:2;O

C34H55O9P (638.3584)


   

PA 22:5/9:1;O

PA 22:5/9:1;O

C34H55O9P (638.3584)


   
   
   
   

ST 28:2;O5;GlcA

ST 28:2;O5;GlcA

C34H54O11 (638.3666)


   

ST 28:3;O6;Hex

ST 28:3;O6;Hex

C34H54O11 (638.3666)


   

2-{[22-(2-chloropropan-2-yl)-2-hydroxy-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-9-yl]oxy}oxane-3,4,5-triol

2-{[22-(2-chloropropan-2-yl)-2-hydroxy-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-9-yl]oxy}oxane-3,4,5-triol

C35H55ClO8 (638.3585)


   

n-[(2s)-1-oxo-1-{[(6z,8e,10e,14s,15s,16e)-3,15,22,24-tetrahydroxy-5-methoxy-14,16-dimethyl-2-azabicyclo[18.3.1]tetracosa-1(24),2,6,8,10,16,20,22-octaen-13-yl]oxy}propan-2-yl]cyclohexanecarboximidic acid

n-[(2s)-1-oxo-1-{[(6z,8e,10e,14s,15s,16e)-3,15,22,24-tetrahydroxy-5-methoxy-14,16-dimethyl-2-azabicyclo[18.3.1]tetracosa-1(24),2,6,8,10,16,20,22-octaen-13-yl]oxy}propan-2-yl]cyclohexanecarboximidic acid

C36H50N2O8 (638.3567)


   

(2s,3r,4s,5r)-2-{[(1s,2r,3s,4r,7r,9s,12r,14s,17r,18r,19r,21r,22s)-22-(2-chloropropan-2-yl)-2-hydroxy-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-9-yl]oxy}oxane-3,4,5-triol

(2s,3r,4s,5r)-2-{[(1s,2r,3s,4r,7r,9s,12r,14s,17r,18r,19r,21r,22s)-22-(2-chloropropan-2-yl)-2-hydroxy-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-9-yl]oxy}oxane-3,4,5-triol

C35H55ClO8 (638.3585)


   

n-[(2r)-1-oxo-1-{[(5r,6z,8z,10z,13s,14r,15r,16z)-3,15,22,24-tetrahydroxy-5-methoxy-14,16-dimethyl-2-azabicyclo[18.3.1]tetracosa-1(24),2,6,8,10,16,20,22-octaen-13-yl]oxy}propan-2-yl]cyclohexanecarboximidic acid

n-[(2r)-1-oxo-1-{[(5r,6z,8z,10z,13s,14r,15r,16z)-3,15,22,24-tetrahydroxy-5-methoxy-14,16-dimethyl-2-azabicyclo[18.3.1]tetracosa-1(24),2,6,8,10,16,20,22-octaen-13-yl]oxy}propan-2-yl]cyclohexanecarboximidic acid

C36H50N2O8 (638.3567)


   

16-hydroxy-19-({5-hydroxy-6-methyl-4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan-6-one

16-hydroxy-19-({5-hydroxy-6-methyl-4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan-6-one

C34H54O11 (638.3666)


   

n-[(2r)-1-oxo-1-{[(5r,6e,8e,10e,13s,14s,15r,16e)-3,15,22,24-tetrahydroxy-5-methoxy-14,16-dimethyl-2-azabicyclo[18.3.1]tetracosa-1(24),2,6,8,10,16,20,22-octaen-13-yl]oxy}propan-2-yl]cyclohexanecarboximidic acid

n-[(2r)-1-oxo-1-{[(5r,6e,8e,10e,13s,14s,15r,16e)-3,15,22,24-tetrahydroxy-5-methoxy-14,16-dimethyl-2-azabicyclo[18.3.1]tetracosa-1(24),2,6,8,10,16,20,22-octaen-13-yl]oxy}propan-2-yl]cyclohexanecarboximidic acid

C36H50N2O8 (638.3567)


   

(1r,2s,4s,7s,8r,9s,12s,13r,16s,18s,19s)-16-hydroxy-19-{[(2r,4r,5r,6r)-5-hydroxy-6-methyl-4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan-6-one

(1r,2s,4s,7s,8r,9s,12s,13r,16s,18s,19s)-16-hydroxy-19-{[(2r,4r,5r,6r)-5-hydroxy-6-methyl-4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan-6-one

C34H54O11 (638.3666)


   

n-(1-oxo-1-{[(8e,10e,16z)-3,15,22,24-tetrahydroxy-5-methoxy-14,16-dimethyl-2-azabicyclo[18.3.1]tetracosa-1(24),2,6,8,10,16,20,22-octaen-13-yl]oxy}propan-2-yl)cyclohexanecarboximidic acid

n-(1-oxo-1-{[(8e,10e,16z)-3,15,22,24-tetrahydroxy-5-methoxy-14,16-dimethyl-2-azabicyclo[18.3.1]tetracosa-1(24),2,6,8,10,16,20,22-octaen-13-yl]oxy}propan-2-yl)cyclohexanecarboximidic acid

C36H50N2O8 (638.3567)


   
   

(2s)-2-[(3r,4s,8r,9r,10r,11s,14s)-4,9-dihydroxy-14-(methoxymethyl)-3,10-dimethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-{[(2-methylbut-3-en-2-yl)oxy]methyl}oxan-2-yl]oxy}tricyclo[9.3.0.0³,⁷]tetradeca-1,6-dien-6-yl]propyl acetate

(2s)-2-[(3r,4s,8r,9r,10r,11s,14s)-4,9-dihydroxy-14-(methoxymethyl)-3,10-dimethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-{[(2-methylbut-3-en-2-yl)oxy]methyl}oxan-2-yl]oxy}tricyclo[9.3.0.0³,⁷]tetradeca-1,6-dien-6-yl]propyl acetate

C34H54O11 (638.3666)